Customizable Drug Eluting Stents

Translumina, a specialist for cardiovascular devices, has developed a unique stent coating technology consisting of the pre-mounted stent system Yukon DES and a specially designed Stent Coating Machine. This machine allows application of a free choice of drug at individual doses on the Yukon DES platform.

The drug coating process takes place directly in the Cath-Lab allowing the interventionalist freedom to adjust treatment dependant on the patient requirements. The stent system with porous surface enables the individual application of drug and/or dosage without having to use polymers. Translumina presented first 12-months results in summer 2005. Further human trials are ongoing.

Whitepaper-Download (2.87 MB)